PD18-08 TUMOR SIZE REDUCTION (≥10%) RESULTING FROM PRE-SURGICAL SYSTEMIC THERAPY PREDICTS IMPROVED SURVIVAL FOLLOWING CYTOREDUCTIVE NEPHRECTOMY

Authors

Richard Barry Sirard, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

5-2024

Volume

211

Issue

5

First Page

435

Last Page

435

Published In/Presented At

Shapiro, Daniel D.; Karam, Jose A.; Master, Viraj A.; Spiess, Philippe E.; Peyton, Charles C.; Dolan, Brendan; Sirard, R. Barry; Robertson, Nicholas D.; Patel, Kartik R.; Jani, Amber; Patil, Dattatraya; Nicaise, Edouard; Manley, Brandon J.; Sexton, Wade J.; Allen, Glenn O.; Matin, Surena F.; Abel, Edwin J.. PD18-08 TUMOR SIZE REDUCTION (≥10%) RESULTING FROM PRE-SURGICAL SYSTEMIC THERAPY PREDICTS IMPROVED SURVIVAL FOLLOWING CYTOREDUCTIVE NEPHRECTOMY. The Journal of Urology 211(5S):p e435, May 2024. | DOI: 10.1097/01.JU.0001008596.32809.c5.08

Disciplines

Medical Education | Medicine and Health Sciences

Department(s)

USF-LVHN SELECT Program, USF-LVHN SELECT Program Students

Document Type

Article